Ginsenosides for Multi-target Intervention in Alzheimer's Disease: Current Evidence, Challenges, and Future Directions.
- 2026-01
- Review
- Molecular neurobiology 63(1)
- Ghaleb Oriquat
- Afaq Mahdi Ali
- Malathi H
- Israa Abdulhameed Ahmad
- Laxmidhar Maharana
- Laxmidhar Maharana
- Ashish Singh Chauhan
- Vimal Arora
- Bilakshan Purohit
- Manoj Kumar-Mishra
- PubMed: 42141250
- DOI: 10.1007/s12035-026-05910-z
- Low evidence
Limited clinical evidence from small open-label trials of Korean Red Ginseng suggests cognitive improvements (e.g., in ADAS-cog and MMSE scores), with good tolerability.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes